← Back to all recallsDRUG RECALL
Niacin Extended-release Tablets
Lannett is recalling 1,000 mg Niacin Extended-release Tablets due to failed dissolution specifications.
What to do
Contact your healthcare provider or pharmacist to discuss alternative treatment options and return the affected medication to your pharmacy.
Why it was recalled
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
How to identify it
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
Official source
Other recent recalls from Lannett Company Inc.
Editorial summary by Recall Canary · last updated 2026-06-04 · primary source: U.S. Food and Drug Administration